Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/article/10.1007/s00520-017-3885-3/fulltext.html
Reference16 articles.
1. Paes FM, Serafni AN (2010) Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. Sem Nucl Med 40:89–104
2. Pandit-Taskar N, Batraki M, Divgi CR (2004) Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. J Nucl Med 45:1358–1365
3. Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, Fogelman I, Houston S, Fauser A, Fischer M, Wilkins D (1997) A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 33:1583–1591
4. Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA (1998) Palliation of pain associated with metastatic bone cancer using samarium-153lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16:1574–1581
5. Tian JH, Zhang JM, Hou QT, Oyang QH, Wang JM, Luan ZS, Chuan L, He YJ (1999) Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylenediaminetetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China. Eur J Nucl Med 26:2–7
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment;European Journal of Nuclear Medicine and Molecular Imaging;2023-11-07
2. Influence of metal on coordination geometry and solution dynamics in complexes of cis-ethylenebis(diphenylphosphine oxide) and Ln(OTf)3 (Ln = La, Sm, Lu) X-ray crystal structures and NMR titration studies;Polyhedron;2023-11
3. Kemik Metastazlarının Tedavisinde Radyofarmasötiklerin Rolü;Fabad Journal of Pharmaceutical Sciences;2023-05-02
4. Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics;Pharmaceutics;2023-03-17
5. Skeletal Complications;Holland‐Frei Cancer Medicine;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3